Baroreflex Activation Therapy In Heart Failure—the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) Trial Rationale and Design

Journal of Cardiac Failure · Published 2026-05-01 · DOI 10.1016/j.cardfail.2026.04.023

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.cardfail.2026.04.023

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles